Design and synthesis of novel fluoro amino acids: synthons for potent macrocyclic HCV NS3 protease inhibitors

被引：7

作者：

Nair, Latha G. ^{[1
]}

Bogen, Stephane ^{[1
]}

Bennett, Frank ^{[1
]}

Chen, Kevin ^{[1
]}

Vibulbhan, Bancha ^{[1
]}

Huang, Yuhua ^{[1
]}

Yang, Weing ^{[1
]}

Doll, Ronald J. ^{[1
]}

Shih, N. -Y. ^{[1
]}

Njoroge, F. George ^{[1
]}

机构：

[1] Merck Res Labs, Kenilworth, NJ 07033 USA

来源：

TETRAHEDRON LETTERS | 2010年 / 51卷 / 23期

关键词：

HEPATITIS-C VIRUS; METATHESIS CATALYSTS; SERINE-PROTEASE; DISCOVERY; OPTIMIZATION; REPLICATION; STRATEGIES; AGENT; SAR;

D O I：

10.1016/j.tetlet.2010.04.010

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

The Hepatitis C Virus (HCV) is a major health hazard and its infection is a leading cause of chronic liver disease world wide. In our efforts toward the discovery of a back up to our first clinical candidate, Boceprevir (SCH 503034), we approached the depeptidization of the molecule through macrocyclization. Herein we report the design and synthesis of fluor amino acids with desired stereochemistry required for the synthesis of macrocyclic inhibitors with fluorine at various positions idle aliphatic chain. Biological activities of representative examples are also reported. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：3057 / 3061

页数：5

共 50 条

[1] Macrocyclic inhibitors of HCV NS3 protease
Venkatraman, Srikanth
Njoroge, F. George
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (09) : 1277 - 1303
[2] Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates
Li, Xianfeng
Zhang, Yong-Kang
Liu, Yang
Ding, Charles Z.
Zhou, Yasheen
Li, Qun
Plattner, Jacob J.
Baker, Stephen J.
Zhang, Suoming
Kazmierski, Wieslaw M.
Wright, Lois L.
Smith, Gary K.
Grimes, Richard M.
Crosby, Renae M.
Creech, Katrina L.
Carballo, Luz H.
Slater, Martin J.
Jarvest, Richard L.
Thommes, Pia
Hubbard, Julia A.
Convery, Maire A.
Nassau, Pamela M.
McDowell, William
Skarzynski, Tadeusz J.
Qian, Xuelei
Fan, Dazhong
Liao, Liang
Ni, Zhi-Jie
Pennicott, Lewis E.
Zou, Wuxin
Wright, Jon
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (19) : 5695 - 5700
[3] Highly potent inhibitors of HCV NS3 protease
Venables, Brian
Sin, Ny
Wang, Alan
Sun, Li-Qiang
Hernandez, Dennis
Sheaffer, Amy
Lee, Min
Barry, Diana
Friborg, Jacques
Yu, Fei
Knipe, Jay
Sandquist, Jason
Good, Andrew C.
Mcphee, Fiona
Meanwell, Nicholas A.
Scola, Paul M.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[4] Evolution of potent inhibitors of HCV NS3 protease
Pessi, A
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U313 - U313
[5] Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease
Li, Xianfeng
Zhang, Yong-Kang
Liu, Yang
Ding, Charles Z.
Li, Qun
Zhou, Yasheen
Plattner, Jacob J.
Baker, Stephen J.
Qian, Xuelei
Fan, Dazhong
Liao, Liang
Ni, Zhi-Jie
White, Gemma V.
Mordaunt, Jackie E.
Lazarides, Linos X.
Slater, Martin J.
Jarvest, Richard L.
Thommes, Pia
Ellis, Malcolm
Edge, Colin M.
Hubbard, Julia A.
Somers, Don
Rowland, Paul
Nassau, Pamela
McDowell, Bill
Skarzynski, Tadeusz J.
Kazmierski, Wieslaw M.
Grimes, Richard M.
Wright, Lois L.
Smith, Gary K.
Zou, Wuxin
Wright, Jon
Pennicott, Lewis E.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3550 - 3556
[6] Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease
Li, Xianfeng
Zhang, Yong-Kang
Liu, Yang
Zhang, Suoming
Ding, Charles Z.
Zhou, Yasheen
Plattner, Jacob J.
Baker, Stephen J.
Liu, Liang
Bu, Wei
Kazmierski, Wieslaw M.
Wright, Lois L.
Smith, Gary K.
Jarvest, Richard L.
Duan, Maosheng
Ji, Jing-Jing
Cooper, Joel P.
Tallant, Matthew D.
Crosby, Renae M.
Creech, Katrina
Ni, Zhi-Jie
Zou, Wuxin
Wright, Jon
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (24) : 7493 - 7497
[7] Design, Synthesis, and Evaluation of Oxygen-Containing Macrocyclic Peptidomimetics as Inhibitors of HCV NS3 Protease
Velazquez, Francisco
Venkatraman, Srikanth
Blackman, Melissa
Pinto, Patrick
Bogen, Stephane
Sannigrahi, Mousumi
Chen, Kevin
Pichardo, John
Hart, Andrea
Tong, Xiao
Girijavallabhan, Viyyoor
Njoroge, F. George
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (03) : 700 - 708
[8] Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease
Rudd, Michael T.
McCauley, John A.
Romano, Joseph J.
Butcher, John W.
Bush, Kimberly
McIntyre, Charles J.
Nguyen, Kevin T.
Gilbert, Kevin F.
Lyle, Terry A.
Holloway, M. Katharine
Wan, Bang-Lin
Vacca, Joseph P.
Summa, Vincenzo
Harper, Steven
Rowley, Michael
Carroll, Steven S.
Burlein, Christine
DiMuzio, Jillian M.
Gates, Adam
Graham, Donald J.
Huang, Qian
Ludmerer, Steven W.
McClain, Stephanie
McHale, Carolyn
Stahlhut, Mark
Fandozzi, Christine
Taylor, Anne
Trainor, Nicole
Olsen, David B.
Liverton, Nigel J.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (23) : 7201 - 7206
[9] Identification of novel HCV NS3 protease inhibitors
O'Meara, Jeff A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[10] Synthesis and biological activity of macrocyclic inhibitors of hepatitis C virus (HCV) NS3 protease
Chen, KX
Njoroge, FG
Prongay, A
Pichardo, J
Madison, V
Girilavallabhan, V
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (20) : 4475 - 4478

← 1 2 3 4 5 →